These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8051399)

  • 1. Immune dysregulation in TGF-beta 1-deficient mice.
    Christ M; McCartney-Francis NL; Kulkarni AB; Ward JM; Mizel DE; Mackall CL; Gress RE; Hines KL; Tian H; Karlsson S
    J Immunol; 1994 Sep; 153(5):1936-46. PubMed ID: 8051399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 2. Generation of TGF-beta-producing regulatory T cells.
    Yoshida M; Kezuka T; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3862-70. PubMed ID: 11053287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrasting effect of transforming growth factor type beta 1 (TGF-beta 1) on proliferation and interleukin-2 receptor expression in activated and rapidly cycling immature (CD3-CD4-CD8-) thymocytes.
    Dupuy d'Angeac A; Rème T; Monier S; Gao Q; Duperray C; Jullien P; Dornand J
    J Cell Physiol; 1993 Jan; 154(1):44-52. PubMed ID: 8419406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-2 receptor alpha-chain expression is independently regulated in primary and secondary lymphoid organs.
    Demaison C; Fiette L; Blanchetière V; Schimpl A; Thèze J; Froussard P
    J Immunol; 1998 Aug; 161(4):1977-82. PubMed ID: 9712069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune Sjögren's-like lesions in salivary glands of TGF-beta1-deficient mice are inhibited by adhesion-blocking peptides.
    McCartney-Francis NL; Mizel DE; Redman RS; Frazier-Jessen M; Panek RB; Kulkarni AB; Ward JM; McCarthy JB; Wahl SM
    J Immunol; 1996 Aug; 157(3):1306-12. PubMed ID: 8757639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor type beta 1 (TGF-beta 1) down-regulates interleukin-2 production and up-regulates interleukin-2 receptor expression in a thymoma cell line.
    D'Angeac AD; Dornand J; Emonds-Alt X; Jullien P; Garcia-Sanz JA; Erard F
    J Cell Physiol; 1991 Jun; 147(3):460-9. PubMed ID: 2066366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 1. Inhibition of T-cell activation in vitro by direct cell-to-cell contact.
    Yoshida M; Takeuchi M; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):811-21. PubMed ID: 10711698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burn-induced thymic apoptosis corresponds with altered TGF-beta(1) and Smad 2/3.
    Hobson KG; Cho K; Adamson LK; Greenhalgh DG
    J Surg Res; 2002 Jun; 105(1):4-9. PubMed ID: 12069494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the activation profile of dendritic cells derived from the bone marrow of interleukin-12/interleukin-23-deficient mice.
    Bastos KR; de Deus Vieira de Moraes L; Zago CA; Marinho CR; Russo M; Alvarez JM; D'Império Lima MR
    Immunology; 2005 Apr; 114(4):499-506. PubMed ID: 15804287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.
    Chen W; Jin W; Hardegen N; Lei KJ; Li L; Marinos N; McGrady G; Wahl SM
    J Exp Med; 2003 Dec; 198(12):1875-86. PubMed ID: 14676299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-2-dependent expression of genes involved in cytoskeleton organization, oncogene regulation, and transcriptional control.
    Herblot S; Chastagner P; Samady L; Moreau JL; Demaison C; Froussard P; Liu X; Bonnet J; Thèze J
    J Immunol; 1999 Mar; 162(6):3280-8. PubMed ID: 10092780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of transforming growth factor-beta on early and late activation events in human T cells.
    Ahuja SS; Paliogianni F; Yamada H; Balow JE; Boumpas DT
    J Immunol; 1993 Apr; 150(8 Pt 1):3109-18. PubMed ID: 8468460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urokinase receptor. An activation antigen in human T lymphocytes.
    Nykjaer A; Møller B; Todd RF; Christensen T; Andreasen PA; Gliemann J; Petersen CM
    J Immunol; 1994 Jan; 152(2):505-16. PubMed ID: 8283034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of macrophage transforming growth factor-beta messenger RNA expression by IL-7.
    Dubinett SM; Huang M; Dhanani S; Wang J; Beroiza T
    J Immunol; 1993 Dec; 151(12):6670-80. PubMed ID: 8258684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High dose oral tolerance in ovalbumin TCR-transgenic mice: systemic neutralization of IL-12 augments TGF-beta secretion and T cell apoptosis.
    Marth T; Strober W; Kelsall BL
    J Immunol; 1996 Sep; 157(6):2348-57. PubMed ID: 8805632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirement of CD28 signaling in homeostasis/survival of TGF-beta converted CD4+CD25+ Tregs from thymic CD4+CD25- single positive T cells.
    Liu Y; Amarnath S; Chen W
    Transplantation; 2006 Oct; 82(7):953-64. PubMed ID: 17038912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel role for TGF-beta and IL-10 in the induction of immune privilege.
    D'Orazio TJ; Niederkorn JY
    J Immunol; 1998 Mar; 160(5):2089-98. PubMed ID: 9498745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-beta enhances macrophage ability to produce IL-10 in normal and tumor-bearing mice.
    Maeda H; Kuwahara H; Ichimura Y; Ohtsuki M; Kurakata S; Shiraishi A
    J Immunol; 1995 Nov; 155(10):4926-32. PubMed ID: 7594497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-beta 1 (TGF-beta1) promotes IL-2 mRNA expression through the up-regulation of NF-kappaB, AP-1 and NF-AT in EL4 cells.
    Han SH; Yea SS; Jeon YJ; Yang KH; Kaminski NE
    J Pharmacol Exp Ther; 1998 Dec; 287(3):1105-12. PubMed ID: 9864299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-beta contributes to the shift toward Th2-type responses through direct and IL-10-mediated pathways in tumor-bearing mice.
    Maeda H; Shiraishi A
    J Immunol; 1996 Jan; 156(1):73-8. PubMed ID: 8598496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.